Trials / Conditions / Recurrent Childhood Non-Hodgkin Lymphoma

Recurrent Childhood Non-Hodgkin Lymphoma

9 registered clinical trials studyying Recurrent Childhood Non-Hodgkin Lymphoma.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or H NCT03210714	National Cancer Institute (NCI)	Phase 2
Completed	Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or H NCT03220035	National Cancer Institute (NCI)	Phase 2
Completed	Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lympho NCT03213691	National Cancer Institute (NCI)	Phase 2
Completed	Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Hist NCT03233204	National Cancer Institute (NCI)	Phase 2
Terminated	Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HS NCT02728700	Stanford University	Phase 1
Completed	Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients NCT01008462	Fred Hutchinson Cancer Center	Phase 2
Completed	Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukem NCT00897325	Children's Oncology Group	—
Completed	Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Tr NCT00027820	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or R NCT00005803	Fred Hutchinson Cancer Center	Phase 1 / Phase 2